Skip to main content

Table 1 Descriptive statistics of baseline variables in colorectal cancer cases and matched control samples

From: Untargeted plasma metabolomics and risk of colorectal cancer—an analysis nested within a large-scale prospective cohort

 

Cases (n = 902)

Controls (n = 902)

p-value

Age at baseline

56.2 (7.4)

56.2 (7.4)

0.826

Age at diagnosis

66.5 (9.1)

-

-

Sex

  

1.000

 Men

462 (51.2%)

462 (51.2%)

 

 Women

440 (48.8%)

440 (48.8%)

 

BMI (kg/m2)a

26.7 (4.0)

26.3 (4.0)

0.015

Cohort

  

1.000

 VIP

820 (91%)

820 (91%)

 

 MONICA

82 (9%)

82 (9%)

 

Freeze and thaw cyclesb

  

 < 0.001

 0

755 (84%)

752 (83%)

 

 1

79 (9%)

109 (12%)

 

 2

44 (5%)

40 (4%)

 

 3

24 (3%)

1 (0%)

 

Fasting status

  

1.000

 0–4 h

27 (3%)

27 (3%)

 

 4–8 h

125 (14%)

125 (14%)

 

 > 8 h

750 (83%)

750 (83%)

 

Storage time (years)

20.9 (5.7)

20.9 (5.7)

0.976

Smoking status

  

0.221

 Nonsmoker

364 (41%)

400 (45%)

 

 Former smoker

335 (38%)

307 (35%)

 

 Current smoker

187 (21%)

173 (20%)

 

 Missing

16

22

 

Education

  

0.359

 Elementary school

348 (39%)

369 (42%)

 

 Secondary school

397 (45%)

362 (41%)

 

 Postsecondary school

141 (16%)

157 (18%)

 

 Missing

16

14

 

Diabetes

  

0.069

 Yes

34 (4%)

20 (2%)

 

 No

863 (96%)

872 (98%)

 

 Missing

5

10

 

Recreational physical activity

  

0.432

 Never

373 (49%)

337 (44%)

 

 Now and then

201 (26%)

212 (28%)

 

 1–2 times/week

98 (14%)

103 (14%)

 

 2–3 times/week

61 (8%)

76 (10%)

 

  > 3 times/week

36 (5%)

30 (4%)

 

 Missing

133

144

 

Alcohol intake (g/day)c

4.1 (5.0)

3.8 (4.7)

0.624

Tumor location

  

-

 Proximal colon

286 (32%)

-

 

 Distal colon

266 (30%)

-

 

 Rectum

342 (38%)

-

 

 Missing

8

-

 

Stage

  

-

 Stages I–II

426 (51%)

-

 

 Stages III–IV

417 (49%)

-

 

 Missing

59

-

 

BRAFd

  

-

 Mutation

140 (20%)

-

 

 Wild type

565 (80%)

-

 

 Missing

197

-

 

KRASd

  

-

 Mutation

154 23%)

-

 

 Wild type

504 (77%)

-

 

 Missing

244

-

 

KRAS/BRAFd

  

-

BRAF

140 (22%)

-

 

KRAS

154 (24%)

-

 

 Both wild type

354 (55%)

-

 

 Missing

254

-

 

MSI status

  

-

 MSS

568 (87%)

-

 

 MSI

87 (13%)

-

 

 Missing

247

-

 
  1. BMI body mass index. VIP Västerbotten Intervention Programme. MONICA Multinational Monitoring of Trends and Determinants in Cardiovascular Disease. MSI microsatellite instability. MSS microsatellite stable. Mean value and standard deviation are reported for continuous variable, whereas counts and percentage are presented for categorical variables. P-values were calculated using paired Wilcoxon signed-rank tests or chi-squared tests. aCases and controls had 5 and 7 missing values, respectively. bPrior to aliquoting for shipment to lab. Of the case–control pairs, 92% were exactly matched on number of freeze–thaw cycles. cCases and controls had 98 and 101 missing values, respectively. dFour of the missing values were samples with both KRAS and BRAF mutation, which were excluded in the subgroup analysis